At entry to the study 43 patients (61%) were using Novopen ® 3 to administer their insulin, 22 (31%) were using syringes, and five (7%) had used a combination of Novopen ® 3 and syringes.

Objective: To assess the functionality and patient acceptability of HumaPen Ergo ®, a new 3.0ml reusable insulin pen. Design: Patients trialled HumaPen Ergo ® (Eli Lilly) over 5 to 7 weeks and ...